Maximiliano Fischer - Profarma Distribuidora Director
| PFRM3 Stock | BRL 7.04 0.32 4.76% |
Director
Mr. Maximiliano Guimaraes Fischer has served as Chief Financial Officer, Investor Relations Officer and a Member of the Executive Board of Profarma Distribuidora de Produtos Farmaceuticos SA since August 6, 2009. He joined the Company in 1993 as its Chief Financial Officer. Prior to joining the Company, he held various positions in the Finance Department of Nova America Textil. He gained a Bachelor in Mechanical Engineering from the Universidade Federal do Rio de Janeiro, a Masters of Business Administration from Instituto Brasileiro de Mercado de Capitais and a Masters of Business Administration from the Universidade Federal do Rio de Janeiro. since 2009.
| Age | 50 |
| Tenure | 15 years |
| Phone | 55 21 4009 0200 |
| Web | https://www.profarma.com.br |
Profarma Distribuidora Management Efficiency
The company has return on total asset (ROA) of 0.0368 % which means that it generated a profit of $0.0368 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0645 %, meaning that it generated $0.0645 on every $100 dollars invested by stockholders. Profarma Distribuidora's management efficiency ratios could be used to measure how well Profarma Distribuidora manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Eduardo Toledo | Odontoprev SA | 54 | |
| Victor Foroni | JHSF Participaes SA | N/A | |
| Carlos Ambrosio | JHSF Participaes SA | N/A | |
| Claudio Bonomi | JHSF Participaes SA | N/A | |
| Thiago Oliveira | JHSF Participaes SA | 52 | |
| Richard Barczinski | JHSF Participaes SA | N/A | |
| Elsen Carvalho | Odontoprev SA | 46 | |
| Samuel Santos | Odontoprev SA | 73 | |
| Samuel Lago | Positivo Tecnologia SA | 45 | |
| Ivan Gontijo | Odontoprev SA | 60 | |
| Cesar Santos | Odontoprev SA | 57 | |
| Luiz Belluzzo | JHSF Participaes SA | 69 | |
| Murilo Passos | Odontoprev SA | 72 | |
| Daniel Brugioni | Mills Estruturas e | N/A | |
| Alvaro Amaral | Positivo Tecnologia SA | 62 | |
| Fernando Mitri | Positivo Tecnologia SA | 66 | |
| Ruben Formighieri | Positivo Tecnologia SA | 56 | |
Management Performance
| Return On Equity | 0.0645 | |||
| Return On Asset | 0.0368 |
Profarma Distribuidora Management Team
Elected by the shareholders, the Profarma Distribuidora's board of directors comprises two types of representatives: Profarma Distribuidora inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Profarma. The board's role is to monitor Profarma Distribuidora's management team and ensure that shareholders' interests are well served. Profarma Distribuidora's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Profarma Distribuidora's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sammy Birmarcker, CEO, Member of the Executive Board, Chairman of the Board | ||
| Adriano Prado, Member Officers | ||
| Maximiliano Fischer, CFO, Director of Investor Relations, Member of the Executive Board |
Profarma Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Profarma Distribuidora a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0645 | |||
| Return On Asset | 0.0368 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 1.35 B | |||
| Shares Outstanding | 122.61 M | |||
| Shares Owned By Insiders | 66.17 % | |||
| Shares Owned By Institutions | 26.52 % | |||
| Price To Earning | (6.45) X | |||
| Price To Book | 0.35 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Profarma Stock Analysis
When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.